Published in Blood Weekly, December 18th, 1995
Data show no risk for the transmission of CJD from pooled plasma products, stated Eva A. Operskalski and James W. Mosley, University of Southern California, Los Angeles, California ("Pooled Plasma Derivatives and Creutzfeldt-Jakob Disease," Lancet, 1995;347:1224).
Operskalski and Mosley indicated that if CJD actually is transmitted by plasma derivatives, then enough time has passed to observe CJD in hemophiliacs, yet no such cases have been...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.